Rocket Lab Stock's Twelve-Month Gain Hides A Long Slide From Its High
Rocket Lab (RKLB) stock rose 79.3% over the past year, outperforming the S&P 500 and peers. Despite a 52.5% revenue increase to $0.77B, its stock dropped from a high of $150.23. The company completed 24 Electron flights, with satellites now driving most revenue. It secured a $397M contract with Space Force and plans to acquire Iridium.
How this was made
The 30-second read
Why it matters
The new $397M contract and expanding backlog provide a concrete growth catalyst that could reverse the recent price decline.
Market read
Contract award and strong Q2 results are material for Rocket Lab and may influence the broader aerospace sector.
What to watch
Potential supply‑chain constraints for satellite components and competition from larger launch providers.
Background
Rocket Lab's stock has risen 79% YTD, but its price recently fell from a $150 high to $73, reflecting valuation concerns despite revenue growth.
Ticker impact
Rocket Lab disclosed a $397 million Space Force contract for its Neutron vehicle and reported Q2 2026 revenue of $0.77 billion with a $2.36 billion backlog.
Potential upside of 5‑10% over the next few weeks as investors price in the new contract.
Large government contract and accelerating launch cadence are material catalysts for a company of Rocket Lab's size.
Market effects
Strengthens the small‑sat launch segment and may pressure peers like LMT, NOC, LHX.
Positive for U.S. aerospace and defense equities.
Highlights growing U.S. government demand for commercial launch services.
Counterpoint
If launch cadence falters or Neutron delays, the contract may not translate into near‑term earnings.
Key entities
- companyRocket Lab
U.S. listed small‑sat launch provider (ticker RKLB).
- governmentSpace Force
U.S. defense branch awarding the Neutron contract.
%252FSpace%252FRocket%252520launching%252520into%252520space%252520by%252520BEST%252520BACKGROUNDS%252520via%252520Shutterstock.jpg&w=3840&q=75)
